José Alberto Duarte Selected Research

José Alberto Duarte Research Topics

Disease

16	Neoplasms (Cancer) 12/2023 - 11/2013
9	Cardiotoxicity 12/2023 - 11/2006
7	Fibrosis (Cirrhosis) 12/2023 - 02/2015
6	Inflammation (Inflammations) 12/2023 - 06/2010
6	Mitochondrial Diseases (Mitochondrial Disease) 11/2022 - 04/2008
4	Poisoning 12/2015 - 07/2008
3	Renal Insufficiency (Renal Failure) 08/2022 - 12/2015
3	Cachexia 01/2022 - 09/2014
3	Necrosis 05/2021 - 01/2017
3	Tendinopathy (Tendonitis) 11/2020 - 12/2017
3	Pain (Aches) 11/2020 - 07/2018
3	Atrophy 09/2020 - 11/2009
3	Body Weight (Weight, Body) 09/2017 - 04/2013
3	Hyperthermia 01/2016 - 06/2008
3	Heart Failure 02/2015 - 09/2013
2	Wounds and Injuries (Trauma) 01/2023 - 11/2018
2	Carcinogenesis 07/2022 - 02/2015
2	Muscular Atrophy (Muscle Atrophy) 01/2022 - 06/2014
2	Multiple Sclerosis 05/2021 - 12/2020
2	Type 2 Diabetes Mellitus (MODY) 03/2021 - 10/2013
2	Insulin Resistance 03/2021 - 11/2020
2	Carcinoma (Carcinomatosis) 01/2018 - 07/2013
2	Infections 01/2017 - 01/2015
2	Myocardial Infarction 01/2015 - 02/2012
2	Obesity 01/2015 - 09/2004
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2014 - 07/2013
2	Hyperglycemia 11/2013 - 10/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023
1	Pressure Ulcer (Bedsore) 01/2023
1	Ulcer 01/2023
1	Low Back Pain (Lumbago) 10/2022
1	Hyperplasia 07/2022
1	Chronic Disease (Chronic Diseases) 03/2021
1	Dyslipidemias (Dyslipidemia) 03/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2021
1	Abdominal Obesity 03/2021
1	Left Ventricular Dysfunction 09/2020
1	Pulmonary Hypertension 09/2020
1	Glioblastoma (Glioblastoma Multiforme) 08/2018
1	Knee Osteoarthritis 07/2018
1	Edema (Dropsy) 04/2018

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2006
5	AntioxidantsIBA 12/2023 - 09/2013
5	Mitoxantrone (Novantrone)FDA LinkGeneric 05/2021 - 09/2013
5	ParaquatIBA 06/2015 - 07/2008
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 11/2021
3	RNA Polymerase II (RNA Polymerase B)IBA 08/2022 - 12/2015
3	Messenger RNA (mRNA)IBA 09/2020 - 11/2015
3	Biomarkers (Surrogate Marker)IBA 09/2014 - 05/2012
2	Glutathione Peroxidase GPX1IBA 12/2023 - 10/2023
2	Topoisomerase II InhibitorsIBA 10/2023 - 11/2021
2	InterleukinsIBA 10/2023 - 09/2017
2	salicylhydroxamic acid (SHAM)IBA 01/2023 - 11/2018
2	Citrate (si)-Synthase (Synthase, Citrate)IBA 11/2022 - 01/2018
2	ProteomeIBA 07/2022 - 11/2009
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2021
2	CytokinesIBA 01/2022 - 02/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 11/2009
2	UbiquitinIBA 01/2022 - 11/2009
2	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 11/2020
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2016 - 10/2008
2	MyostatinIBA 02/2015 - 07/2013
2	Phospholipids (Phosphatides)FDA LinkGeneric 06/2014 - 10/2013
2	Streptozocin (Streptozotocin)FDA Link 11/2013 - 08/2012
2	AntidotesIBA 04/2013 - 07/2008
2	HerbicidesIBA 04/2013 - 09/2009
2	Ethanol (Ethyl Alcohol)IBA 10/2008 - 06/2008
1	Peroxidase (Myeloperoxidase)IBA 12/2023
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2023
1	CatalaseIBA 10/2023
1	Type I Tumor Necrosis Factor ReceptorsIBA 10/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2023
1	p38 Mitogen-Activated Protein KinasesIBA 10/2023
1	CollagenIBA 09/2023
1	Adenosine Diphosphate (ADP)IBA 11/2022
1	Neprilysin (Neutral Endopeptidase)IBA 07/2022
1	TranscortinIBA 07/2022
1	ClusterinIBA 07/2022
1	Beclin-1IBA 01/2022
1	NF-kappa B (NF-kB)IBA 11/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 11/2021
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 11/2020
1	Endothelin-1 (Endothelin 1)IBA 09/2020
1	MonocrotalineIBA 09/2020
1	AmanitinsIBA 01/2019
1	Silicon Dioxide (Silica)FDA LinkGeneric 08/2018
1	GoldIBA 07/2018
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 04/2018

Therapy/Procedure

4	Therapeutics 10/2023 - 06/2010
2	Low-Level Light Therapy (LLLT) 11/2020 - 07/2018
2	Massage (Zone Therapy) 09/2020 - 12/2017
1	Activities of Daily Living (ADL) 10/2022
1	Resistance Training 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 11/2020
1	Extracorporeal Shockwave Therapy 11/2020
1	Analgesia 09/2020
1	Transcutaneous Electric Nerve Stimulation (TENS) 07/2018
1	Conservative Treatment 07/2018